Clinical trial reportBritish journal of cancerPublished
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors
Regional connection
Verified Author affiliations on the Europe PMC record name GSK, Merck & Co., Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- GSK, Merck & Co., Perelman School of Medicine, University of Pennsylvania
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- British journal of cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neoplasms; Antineoplastic Agents; Enzyme Inhibitors; Treatment Outcome; Maximum Tolerated Dose; Adult
- PubMed ID
- 37237172
- PubMed Central ID
- PMC10338470
- Open access
- Yes, open
- Added to directory
- Source checked